Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FD4YL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,406
Award facts
- Contract value 100% obligated
- $19,405.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,405.50 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 Unit Vials. The contract, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has established itself as a key supplier within the federal pharmaceutical supply chain. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems nationwide. This delivery order for Botox reflects the contractor's ongoing role in supplying specialized pharmaceutical products to support DoD medical operations, consistent with its demonstrated capability in managing complex pharmaceutical procurement across the DLA's extensive product portfolio.
Quick answers
Who was awarded contract SPE2DB25FD4YL?
SPE2DB25FD4YL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FD4YL worth?
The government has obligated $19,406 on SPE2DB25FD4YL.
Is contract SPE2DB25FD4YL an order under another contract?
Yes. SPE2DB25FD4YL is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB25FD4YL competed?
The extent of competition for SPE2DB25FD4YL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award